Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119772) titled 'Urinary proteomics predicts the clinical efficacy of SGLT2 inhibitors in patients with chronic kidney disease' on March 3.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: First Medical Center of Chinese PLA General Hospital
Condition:
Chronic kidney disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Single-arm observational cohort:600;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293920
Published by HT Digital Content Services with permission from Health Daily ...